DGAP-News: EOS System Ultra-Low Dose and 3D Imaging Featured at RSNA Annual Meeting

EOS imaging

01.12.2011 20:30
—————————————————————————

Two New Studies Highlight Utility of System for Improved Adolescent Orthopedic
Care

CAMBRIDGE, Mass. and PARIS, 2011-12-01 20:30 CET (GLOBE NEWSWIRE) —
EOS imaging, leader in orthopedic imaging, announces two new studies evaluating
the benefits of ultra-low dose and 3D imaging of lower limbs in adolescent
patients. The data were presented at the Radiological Society of North America
(RSNA) 97th Annual Meeting, November 27-December 2, Chicago, IL.

Marie Meynadier, PhD, CEO, EOS imaging, said, –These new clinical studies
further support the utility of EOS for the adolescent orthopedic population for
both its ultra-low dose and, now for the first time, the benefits of 3D
modeling. We are pleased that this research continues to instill confidence in
the technology, and represents the versatility of the 3D imaging beyond the
spine to assist in the correction of lower limb deformities.–

The first study, –Dose and Scoliosis Radiographic Examination: How Can a
Slit-scanning System Reduce Considerably Irradiation by Managing Scatter
Reduction?,– was presented by Sylvain Deschenes, PhD, of CHU Sainte-Justine,
Montreal, Quebec. Researchers compared image quality and clinical radiation
dose of the slit-scanning EOS imaging system vs. that of full-field digital
radiography (DR), and evaluated the actual dose of each method for scoliosis
exams.

EOS imaging technology was found to reduce radiation dose considerably in
musculoskeletal radiographic examination, particularly for scoliosis follow-ups
where the effective dose was seven times lower than DR. Additionally,
researchers concluded that image quality benefits from the improved efficacy in
blocking scatter radiation, enabling EOS to deliver quality images with
substantially less radiation.

–The radiation dose associated with traditional imaging is a clinical concern
in instances where multiple X-rays are needed to appropriately manage the
patient, such as with adolescent idiopathic scoliosis. This study is part of a
growing body of research supporting the significant dose reduction associated
with slit-scanning without compromising the quality of the image, allowing for
overall improved patient care and peace of mind for patients and their
families,– said Dr. Deschenes.

The EOS System was also featured in the poster presentation, titled
–Three-dimensional Evaluation of the Lower Limbs in Adolescents Using the EOS
System,– presented by investigator Ramon Gheno, MD, Lille, France. This is the
first clinical study to analyze the utility of 3D imaging to evaluate
misalignment of the lower limbs in children and adolescents. It was also
published in the September 2011 edition of European Radiology.

Two radiologists retrospectively analyzed two and three-dimensional
measurements of 47 lower limbs of 27 randomized patients. The analysis was
performed using EOS 3D imaging and a conventional imaging processor (Osirix(r))
for 2D measurements. The data demonstrates 3D imaging enabled by EOS delivers
superior or equivalent dimensional measurements for several key parameters used
to evaluate lower limb alignment, such as tibial and femoral length, or frontal
and lateral knee angulations.

–This study is the first to use 3D imaging to evaluate lower extremity
alignment among the pediatric population. The experience suggests 3D imaging
with EOS, especially in the weight-bearing standing position, offers a more
precise assessment of abnormal alignment that can significantly benefit surgery
planning and enable better understanding of potential, long-term secondary
degenerative diseases,– said Dr. Gheno.

The EOS system allows for a single, full body or localized image with an
ultra-low dose, documented to be up to nine times less than conventional
computed radiography systems and more than 100 times below that of one CT scan.
The Nobel-prize winning technology and proprietary software technology provide
3D imaging of the patient skeleton and automatically calculates a broad range
of clinical parameters essential to diagnosis and surgical planning. Images can
be obtained in standing or seated weight-bearing positions to reflect the bone
and joint status of the patient–s posture. The system has been used in over
100,000 procedures to date across North America, Europe, Asia and Australia.

About EOS imaging

EOS was developed from a Nobel Prize-winning technology by a team of engineers,
orthopedic surgeons and radiologists as a complete orthopedic imaging solution.
EOS allows full-body imaging of patients that enables global assessment of
balance and posture as well as a 3D bone-envelope image in a weight-bearing
position, and provides automatically over 100 clinical parameters to the
orthopedic surgeon for pre- and post-operative surgical planning. EOS is a
total solution in orthopedic imaging available in the U.S. since receiving FDA
510(k) clearance. The company EOS imaging has corporate headquarters in
Cambridge, Mass. (185 Alewife Brook Parkway, Suite 410; toll-free:
+1-866-933-5301), and Paris, as well as an office in Montreal. Learn more at:
www.eos-imaging.com.

CONTACT: Company Contact:
Herve Legrand
Vice President Sales&Marketing, North America
(678) 564-5400
hlegrand@eos-imaging.com

Media Contact:
Lisa Cook
(646) 536-7012
lcook@theruthgroup.com
News Source: NASDAQ OMX

01.12.2011 Dissemination of a Corporate News, transmitted by DGAP –
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP–s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

—————————————————————————

Language: English
Company: EOS imaging

United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9901780711
WKN:

End of Announcement DGAP News-Service

—————————————————————————

  eos-system-ultra-low-dose-and-3d-imaging-featured-at-rsna-annual-meeting